EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Recent Advances in Gastrointestinal Indolent B-Cell Lymphomas

Yimeng Zhao, Weihua Yin, Xingen Wang

Lymphatics · 18.03.2026 · 4 (1) · 16

DOI: 10.3390/lymphatics4010016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lymphatics, online erschienen am 18.03.2026. Verfasst von Yimeng Zhao und 2 weiteren Autor:innen. Die Arbeit nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastrointestinal indolent B-cell lymphomas (GI-iBCLs) are a group of low-grade, slowly progressive malignancies, accounting for approximately 1–4% of all gastrointestinal tumors. They represent the most common type of extranodal indolent B-cell lymphoma. Their clinical presentation often overlaps with that of benign inflammatory conditions, posing diagnostic challenges. In recent years, the incidence of GI-iBCL has been increasing in Asia and Europe, while advances in molecular pathology have facilitated more precise classification. This review systematically summarizes recent progress in understanding the epidemiology, clinical features, pathogenesis, pathological characteristics, treatment, and prognosis of GI-iBCLs, with a specific focus on mucosa-associated lymphoid tissue (MALT) lymphoma and duodenal-type follicular lymphoma (DTFL). We also discuss critical issues such as the risk of histological transformation, treatment optimization for refractory cases, the potential of molecular markers, and the evolving landscape of precision medicine.

Zitieren

APA

Zhao, Y., Yin, W., & Wang, X. (2026). Recent Advances in Gastrointestinal Indolent B-Cell Lymphomas. Lymphatics, 4(1), 16. https://doi.org/10.3390/lymphatics4010016

Vancouver

Zhao Y, Yin W, Wang X. Recent Advances in Gastrointestinal Indolent B-Cell Lymphomas. Lymphatics. 2026;4(1):16. doi:10.3390/lymphatics4010016

BibTeX
@article{Zhao2026,
  author = {Zhao, Yimeng and Yin, Weihua and Wang, Xingen},
  title = {Recent Advances in Gastrointestinal Indolent B-Cell Lymphomas},
  journal = {Lymphatics},
  year = {2026},
  volume = {4},
  number = {1},
  pages = {16},
  doi = {10.3390/lymphatics4010016}
}
Kostenlos starten →